Substituted 5-aminomethy1-1H-pyrrole-2-carboxylic acid amides
    1.
    发明授权
    Substituted 5-aminomethy1-1H-pyrrole-2-carboxylic acid amides 失效
    取代的5-氨基甲基-1H-吡咯-2-羧酸酰胺

    公开(公告)号:US07842812B2

    公开(公告)日:2010-11-30

    申请号:US11600827

    申请日:2006-11-17

    IPC分类号: C07D211/06 A61K31/454

    CPC分类号: C07D207/34

    摘要: Substituted 5-aminomethyl-1H-pyrrole-2-carboxylic acid amides, a process for the production thereof, pharmaceutical preparations containing these compounds and the use of these compounds in pharmaceutical preparations for treatment or inhibition of withdrawal symptoms, memory disorders, neurodegenerative diseases, epilepsy, cardiovascular disorders, water retention, intestinal motility disorders, urinary incontinence, anorexia, tinnitus, pruritus, depression, sexual dysfunction, airways diseases, food intake disorders, or type II (non-insulin-dependent) diabetes, or for anxiolysis, diuresis, suppression of the urinary reflex, reducing the addictive potential of opioids, modulating locomotor activity, influencing the cardiovascular system, or regulating electrolyte balance.

    摘要翻译: 取代的5-氨基甲基-1H-吡咯-2-羧酸酰胺,其制备方法,含有这些化合物的药物制剂以及这些化合物在药物制剂中用于治疗或抑制戒断症状,​​记忆障碍,神经变性疾病, 癫痫,心血管疾病,保水,肠蠕动障碍,尿失禁,厌食症,耳鸣,瘙痒,抑郁症,性功能障碍,气道疾病,食物摄取障碍或II型(非胰岛素依赖型)糖尿病,或用于焦虑症,利尿 抑制尿反射,降低阿片类药物的上瘾潜力,调节运动活性,影响心血管系统或调节电解质平衡。